Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic

Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic Publisher Pubmed

Shakshouk H^{1, 2} ; Daneshpazhooh M³ ; Murrell DF⁴ ; Lehman JS¹

Show Affiliations

1. Department of Dermatology, Mayo Clinic, Rochester, MN, United States
2. Department of Dermatology, Andrology and Venereology, Alexandria University, Alexandria, Egypt
3. Department of Dermatology, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Dermatology, University of New South Wales, Sydney, Australia

Source: Journal of the American Academy of Dermatology Published:2020

Abstract

[No abstract available]

2. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)

3. Sixteen-Year History of Rituximab Therapy for 1085 Pemphigus Vulgaris Patients: A Systematic Review, International Immunopharmacology (2018)

4. Updated S2k Guidelines on the Management of Pemphigus Vulgaris and Foliaceus Initiated by the European Academy of Dermatology and Venereology (Eadv), Journal of the European Academy of Dermatology and Venereology (2020)

5. Burden of Pemphigus Vulgaris With a Particular Focus on Women: A Review, International Journal of Women's Dermatology (2022)

Experts (# of related papers)

View all Related Experts

Maryam Daneshpajooh (3)

Hamid Reza Mahmoodi (2)

Style	Citing Format
MLA	Shakshouk H, et al.. "Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic." Journal of the American Academy of Dermatology, vol. 82, no. 6, 2020, pp. e235-e236.
APA	Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS (2020). Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic. Journal of the American Academy of Dermatology, 82(6), e235-e236.
Chicago	Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS. "Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic." Journal of the American Academy of Dermatology 82, no. 6 (2020): e235-e236.
Harvard	Shakshouk H et al. (2020) 'Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic', Journal of the American Academy of Dermatology, 82(6), pp. e235-e236.
Vancouver	Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS. Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic. Journal of the American Academy of Dermatology. 2020;82(6):e235-e236.
BibTex	@article{ author = {Shakshouk H and Daneshpazhooh M and Murrell DF and Lehman JS}, title = {Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic}, journal = {Journal of the American Academy of Dermatology}, volume = {82}, number = {6}, pages = {e235-e236}, year = {2020} }
RIS	TY - JOUR AU - Shakshouk H AU - Daneshpazhooh M AU - Murrell DF AU - Lehman JS TI - Treatment Considerations for Patients With Pemphigus During the Covid-19 Pandemic JO - Journal of the American Academy of Dermatology VL - 82 IS - 6 SP - e235 EP - e236 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract